Navigation Links
Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
Date:12/12/2012

BETHESDA, Md., Dec. 12, 2012 /PRNewswire/ --Northwest Biotherapeutics, Inc. (Nasdaq: NWBO; NWBOW), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 450,000 shares of common stock and warrants to purchase 225,000 shares, at a public offering price of $4.00 per share and $0.01 per warrant in connection with its previously announced underwritten public offering of 3,000,000 shares of common stock and warrants to purchase 1,500,000 shares of common stock, bringing total gross proceeds from the offering to $13.8 million.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

The Warrants have a per share exercise price of $5.00, are exercisable immediately, and expire 5 years from the date of issuance.

Aegis Capital Corp. is acting as the sole book-running manager for this offering. 

A registration statement on Form S-1 relating to the shares and warrants was filed with the Securities and Exchange Commission and is effective.  A final prospectus relating to the offering has been filed with the SEC and is available on the SEC's web site at http://www.sec.gov.  Copies of the final prospectus relating to the offering, may be obtained from the offices of Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY, 10019, telephone: 212-813-1010 or email: prospectus@aegiscap.com., or from the above-mentioned SEC website. 

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other juri
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Northwest Biotherapeutics Announces Public Offering of Common Stock and Warrants, and Listing on NASDAQ
2. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
3. Northwest Bio Awarded $5.5 Million German Government Grant
4. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
5. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
6. River Vision Announces Completion of $17 million Series A Financing
7. Winner Medical Announces Closing of Going Private Transaction
8. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
9. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
10. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
11. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   , July 2, 2015 BGI announced ... Hong Kong has been accredited by ... facility is the first clinical next-generation-sequencing laboratory to receive ... meeting the highest standard in clinical laboratory practices. Complementary to ... compliant laboratory process, and multiple ISO certifications, the CAP ...
(Date:7/1/2015)... , July 1, 2015 The ... group of state and regional professional rheumatology societies, ... of rheumatologists that explored perceptions of biosimilars and ... patients. Biosimilars are medicines that ... medicines. They are notably different from generic medications ...
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and ... for the second quarter of 2015 on Thursday, July 23, ... day with the investment community and media to further detail ... begin at 9 a.m. EDT. Investors, media and the general ... through a link that will be posted on Lilly,s website ...
Breaking Medicine Technology:BGI Receives Accreditation from the College of American Pathologists (CAP) 2Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2
... CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of ... immunoassay segment of the In-Vitro Diagnostics market, announced the selection of ... a portable diagnostic platform designed to produce test results with central ... , , ...
... , June 21 ERT (Nasdaq: ... to the pharmaceutical, biotechnology and medical device industries, announced ... the Tufts Center for the Study of Drug Development, ... The industry-wide report measures the current and anticipated adoption ...
Cached Medicine Technology:CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 2CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 3CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 4ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services 2ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services 3ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services 4
(Date:7/2/2015)... ... 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was fully ... to write his first poem, and three years later he was publishing an entire book ... sharing with the world. "I have always believed that the best way to lift yourself ...
(Date:7/2/2015)... ... , ... Global leader and compression innovator, SIGVARIS North America, is ... For style that’s quick on its feet, men will love this fun new way ... everywhere because a simple change in socks can dramatically help improve overall leg health ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... and Emerging Healthcare Delivery Coalition met for the late June Web-based session, the ... with new reimbursement schemes and managing high-risk patients through coordinated care. , During ...
(Date:7/2/2015)... ... July 02, 2015 , ... Facial ... care and precision. There is an art and science that goes into successful ... successfully reshaping the facial features and lives of more than 2,500 satisfied facelift ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at the ... $4 million through five federal grants to study a group of related mosquito-borne ... diseases. , The research will be conducted in the Regional Biocontainment Laboratory ...
Breaking Medicine News(10 mins):Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4
... low in obese women and a recent study accepted for ... Society, reports that mice whose mothers had low ghrelin levels ... Hormones involved in energy balance and metabolism, such as ... and humans. However ghrelin,s role in reproductive tract development remains ...
... Texas MD Anderson Cancer Center has been awarded a grant ... head and neck cancer radiation treatment, can be prevented when ... $2.7 million grant awarded by the National Cancer Institute (NCI) ... score from peer scientists evaluating grant proposals for NCI. ...
... , TUESDAY, March 22 (HealthDay News) -- The serious ... patients will develop pneumonia can be reduced by ... Pneumonia is a looming threat for trauma patients. ... an incidence of 40 percent to 60 percent, mainly ...
... are more likely to be female, suffer from a neurological ... to research published in the March issue of the ... have shown that alcohol abuse by the perpetrator plays a ... Lee Friedman, assistant professor of environmental and occupational health sciences ...
... recruiting patients for a new National Cancer Institute ... drug rosuvastatin is effective in the prevention of ... population studies have shown that patients taking statins, ... fewer colon polyps, which can lead to cancer ...
... Changes that occur in the airways of asthma patients ... interleukin-13 (IL-13) which stimulates invasion of airway cells called ... Duke University. The study is the latest effort by ... in airway remodeling that can cause breathing difficulties in ...
Cached Medicine News:Health News:UT MD Anderson receives grant for study of acupuncture in cancer 2Health News:Steroid May Help Cut Pneumonia Risk After Brain Trauma 2Health News:Steroid May Help Cut Pneumonia Risk After Brain Trauma 3Health News:Elderly victims of abuse often use alcohol or drugs, study says 2Health News:Jefferson clinical trial: Can a cholesterol drug prevent colon cancer? 2Health News:Protein associated with allergic response causes airway changes in asthma patients 2Health News:Protein associated with allergic response causes airway changes in asthma patients 3
... is a high precision optical system for ... the anterior eye segment, based on a ... Placido Disk. , GALILEI combines the advantages ... accuracy curvature data, while Scheimpflug imaging is ...
... The C-VUE 55 Toric Multifocal ... also have presbyopia with all day ... visual acuity at every distance. This ... wide range of parameters with ADDs ...
... Nicknamed the SRS, this new and innovative stent ... the office right at the chair with just ... medical grade silicone and is available in three ... separately). At each end of the stent is ...
... Using flying spot technology the Technolas 217z ... for personalized vision correction, allows surgeons in ... to -7.00 Diopters and astigmatism up to ... combines both a 2mm and 1mm truncated ...
Medicine Products: